FDA approves new drug for metastatic lung cancer
On Oct. 9, the U.S. Food and Drug Administration (FDA) approved Opdivo (nivolumab) to treat patients with metastatic non-small cell lung cancer whose disease progressed during or after…
Reader Survey
Please share your feedback! We’re interested to learn more about your experience with American Nurse Journal.
